Veloxis Pharmaceuticals Announces Initiation of ASERTAA Study of ENVARSUS ... Wall Street Journal The ASERTAA study is designed to compare the pharmacokinetics (PK) of ENVARSUS(R), a once-daily tacrolimus tablet, to generic twice daily tacrolimus capsules in stable African-American renal transplant patients. African-American transplant recipients ... |
